Stock Events

Stock Events

Lumos Diagnostics 

€0.12
10
-€0.01-5.74% Thursday 06:05

Statistics

Day High
0.12
Day Low
0.12
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
90.53M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26FebExpected
Q2 2025
Q4 2025
-0
0.33
0.66
1
Expected EPS
N/A
Actual EPS
-0.0049979085468

Financials

-57.47%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
21.78MRevenue
-12.52MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 7YU.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories offers a broad range of diagnostics products, including rapid diagnostics which compete directly with Lumos Diagnostics' offerings.
QuidelOrtho
QDEL
Mkt Cap1.17B
Quidel Corporation specializes in diagnostic healthcare solutions similar to Lumos Diagnostics, particularly in the areas of infectious disease testing.
Hologic
HOLX
Mkt Cap16.89B
Hologic, Inc. provides diagnostics products and technologies for women's health, competing in the broader diagnostics market.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories, Inc. produces and supplies products and systems used for diagnostic testing, which overlaps with the market Lumos Diagnostics serves.
Quest Diagnostics
DGX
Mkt Cap22.03B
Quest Diagnostics is a provider of diagnostic information services, which includes products that compete in the same space as Lumos Diagnostics.
Labcorp
LH
Mkt Cap22.69B
Laboratory Corporation of America Holdings operates in the same clinical laboratory services sector, offering diagnostic and testing solutions.
Orasure Technologies
OSUR
Mkt Cap212.91M
OraSure Technologies, Inc. develops, manufactures, and markets point-of-care diagnostic tests, directly competing with Lumos Diagnostics' rapid test kits.
Neogenomics
NEO
Mkt Cap1.04B
NeoGenomics Laboratories specializes in cancer diagnostics and pharma services, providing diagnostic solutions that could overlap with Lumos' offerings.
Fulgent Genetics
FLGT
Mkt Cap525.3M
Fulgent Genetics offers genetic testing to detect diseases, indirectly competing with Lumos Diagnostics by providing alternative diagnostic solutions.

About

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
Show more...
CEO
ISIN
AU0000157091
WKN
000A3CYYM

Listings

OTC Link
US
LDXHF
AU
AU
LDX.AU
F
DE
7YU.F

0 Comments

Share your thoughts

FAQ

What is Lumos Diagnostics stock price today?▼
The current price of 7YU.F is €0.12 EUR — it has decreased by -5.74% in the past 24 hours. Watch Lumos Diagnostics stock price performance more closely on the chart.
What is Lumos Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lumos Diagnostics stocks are traded under the ticker 7YU.F.
What is Lumos Diagnostics market cap?▼
Today Lumos Diagnostics has the market capitalization of 90.53M
When is the next Lumos Diagnostics earnings date?▼
Lumos Diagnostics is going to release the next earnings report on September 01, 2026.
What were Lumos Diagnostics earnings last quarter?▼
7YU.F earnings for the last quarter are -0 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Lumos Diagnostics revenue for the last year?▼
Lumos Diagnostics revenue for the last year amounts to 21.78M EUR.
What is Lumos Diagnostics net income for the last year?▼
7YU.F net income for the last year is -12.52M EUR.
When did Lumos Diagnostics complete a stock split?▼
Lumos Diagnostics has not had any recent stock splits.